TY - JOUR
T1 - A pooled analysis of waist circumference and mortality in 650,000 adults
AU - Cerhan, James R.
AU - Moore, Steven C.
AU - Jacobs, Eric J.
AU - Kitahara, Cari M.
AU - Rosenberg, Philip S.
AU - Adami, Hans Olov
AU - Ebbert, Jon O.
AU - English, Dallas R.
AU - Gapstur, Susan M.
AU - Giles, Graham G.
AU - Horn-Ross, Pamela L.
AU - Park, Yikyung
AU - Patel, Alpa V.
AU - Robien, Kim
AU - Weiderpass, Elisabete
AU - Willett, Walter C.
AU - Wolk, Alicja
AU - Zeleniuch-Jacquotte, Anne
AU - Hartge, Patricia
AU - Bernstein, Leslie
AU - De Gonzalez, Amy Berrington
N1 - Funding Information:
Grant Support: The National Institutes of Health–AARP Diet and Health study was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The Breast Cancer Detection Demonstration Project Follow-up Study has been supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The California Teachers Study was supported by National Cancer Institute grant CA77398 and contract 97-10500 from the California Breast Cancer Research Fund. The Cancer Prevention Study II was supported by the American Cancer Society. The Cohort of Swedish Men was supported by the Swedish Research Council, the Swedish Council for Working Life and Social Research, and the Swedish Cancer Society. The Health Professionals Follow-up Study is supported by National Cancer Institute grant P01 CA055075 . The Iowa Women's Health Study is supported by the National Cancer Institute grant R01 CA39742 . The Melbourne Collaborative Cohort Study receives core funding from The Cancer Council Victoria and is additionally supported by grants 209057 , 251533 , and 396414 from the Australian National Health and Medical Research Council . The New York University Women’s Health Study is supported by National Cancer Institute grants R01 CA098661 and P30 CA016087 and by center grant ES000260 from the National Institute of Environmental Health Sciences . The Swedish Mammography Cohort was supported by the Swedish Research Council, Swedish Council for Working Life and Social Research, and the Swedish Cancer Society. The Women’s Lifestyle and Health project was supported by the Swedish Cancer Society and the Swedish Research Council.
PY - 2014/3
Y1 - 2014/3
N2 - Objectives: To assess the independent effect of waist circumference on mortality across the entire body mass index (BMI) range and to estimate the loss in life expectancy related to a higher waist circumference. Patients and Methods: We pooled data from 11 prospective cohort studies with 650,386 white adults aged 20 to 83 years and enrolled from January 1, 1986, through December 31, 2000. We used proportional hazards regression to estimate hazard ratios (HRs) and 95% CIs for the association of waist circumference with mortality. Results: During a median follow-up of 9 years (maximum, 21 years), 78,268 participants died. After accounting for age, study, BMI, smoking status, alcohol consumption, and physical activity, a strong positive linear association of waist circumference with all-cause mortality was observed for men (HR, 1.52 for waist circumferences of ≥110 vs <90 cm; 95% CI, 1.45-1.59; HR, 1.07 per 5-cm increment in waist circumference; 95% CI, 1.06-1.08) and women (HR, 1.80 for waist circumferences of ≥95 vs <70 cm; 95% CI, 1.70-1.89; HR, 1.09 per 5-cm increment in waist circumference; 95% CI, 1.08-1.09). The estimated decrease in life expectancy for highest vs lowest waist circumference was approximately 3 years for men and approximately 5 years for women. The HR per 5-cm increment in waist circumference was similar for both sexes at all BMI levels from 20 to 50 kg/m2, but it was higher at younger ages, higher for longer follow-up, and lower among male current smokers. The associations were stronger for heart and respiratory disease mortality than for cancer. Conclusions: In white adults, higher waist circumference was positively associated with higher mortality at all levels of BMI from 20 to 50 kg/m 2. Waist circumference should be assessed in combination with BMI, even for those in the normal BMI range, as part of risk assessment for obesity-related premature mortality.
AB - Objectives: To assess the independent effect of waist circumference on mortality across the entire body mass index (BMI) range and to estimate the loss in life expectancy related to a higher waist circumference. Patients and Methods: We pooled data from 11 prospective cohort studies with 650,386 white adults aged 20 to 83 years and enrolled from January 1, 1986, through December 31, 2000. We used proportional hazards regression to estimate hazard ratios (HRs) and 95% CIs for the association of waist circumference with mortality. Results: During a median follow-up of 9 years (maximum, 21 years), 78,268 participants died. After accounting for age, study, BMI, smoking status, alcohol consumption, and physical activity, a strong positive linear association of waist circumference with all-cause mortality was observed for men (HR, 1.52 for waist circumferences of ≥110 vs <90 cm; 95% CI, 1.45-1.59; HR, 1.07 per 5-cm increment in waist circumference; 95% CI, 1.06-1.08) and women (HR, 1.80 for waist circumferences of ≥95 vs <70 cm; 95% CI, 1.70-1.89; HR, 1.09 per 5-cm increment in waist circumference; 95% CI, 1.08-1.09). The estimated decrease in life expectancy for highest vs lowest waist circumference was approximately 3 years for men and approximately 5 years for women. The HR per 5-cm increment in waist circumference was similar for both sexes at all BMI levels from 20 to 50 kg/m2, but it was higher at younger ages, higher for longer follow-up, and lower among male current smokers. The associations were stronger for heart and respiratory disease mortality than for cancer. Conclusions: In white adults, higher waist circumference was positively associated with higher mortality at all levels of BMI from 20 to 50 kg/m 2. Waist circumference should be assessed in combination with BMI, even for those in the normal BMI range, as part of risk assessment for obesity-related premature mortality.
UR - http://www.scopus.com/inward/record.url?scp=84898655270&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2013.11.011
DO - 10.1016/j.mayocp.2013.11.011
M3 - Article
C2 - 24582192
AN - SCOPUS:84898655270
SN - 0025-6196
VL - 89
SP - 335
EP - 345
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 3
ER -